| P50 | author | Yanshi Wang | Q91633199 |
| | Shaojie Yang | Q91633203 |
| | Shanshan Zhang | Q91633207 |
| | Xin Wu | Q91633212 |
| P2860 | cites work | Risk factors and treatment for recurrent vulvar squamous cell carcinoma | Q28072964 |
| | Gelatinase-mediated migration and invasion of cancer cells | Q28252032 |
| | TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA | Q28508328 |
| | The Raf/MEK/ERK pathway: new concepts of activation. | Q34454912 |
| | The MAPK pathway across different malignancies: a new perspective | Q34459097 |
| | The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer | Q34765346 |
| | Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. | Q35204486 |
| | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 |
| | Targeting RAS-ERK signalling in cancer: promises and challenges | Q38272894 |
| | Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression | Q38771258 |
| | Potential Signaling Pathways Involved in the Clinical Application of Oxymatrine | Q38831233 |
| | Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells | Q38926824 |
| | Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells | Q39021521 |
| | The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation | Q39232781 |
| | Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma | Q39270291 |
| | Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression | Q39976546 |
| | Oxymatrine inhibits proliferation of human bladder cancer T24 cells by inducing apoptosis and cell cycle arrest | Q41831176 |
| | RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites | Q41879970 |
| | EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. | Q42509418 |
| | Expression and prognostic role of pan-Ras, Raf-1, pMEK1 and pERK1/2 in patients with hepatocellular carcinoma | Q43460415 |
| | Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway | Q45875804 |
| | A comparative study of MMP-2 in vulvar neoplasms | Q47727568 |
| | Oxymatrine Promotes S-Phase Arrest and Inhibits Cell Proliferation of Human Breast Cancer Cells in Vitro through Mitochondria-Mediated Apoptosis | Q47851578 |
| | Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway | Q48133048 |
| | Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway | Q49686713 |
| | Identification of molecular targets in vulvar cancers. | Q50985514 |
| | Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein. | Q53603902 |
| | Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis. | Q54982256 |
| | CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma. | Q55072491 |
| | Oxymatrine induces cell cycle arrest and apoptosis and suppresses the invasion of human glioblastoma cells through the EGFR/PI3K/Akt/mTOR signaling pathway and STAT3. | Q55456638 |
| | Porcine reproductive and respiratory syndrome virus inhibits MARC-145 proliferation via inducing apoptosis and G2/M arrest by activation of Chk/Cdc25C and p53/p21 pathway | Q58609060 |
| | KIT pathway alterations in mucosal melanomas of the vulva and other sites | Q84379968 |
| | HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer | Q89099879 |
| | Oxymatrine inhibits the migration and invasion of hepatocellular carcinoma cells by reducing the activity of MMP-2/-9 via regulating p38 signaling pathway | Q90837509 |
| | Vulvar Cancer | Q91226912 |
| | IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway | Q92243738 |
| | Oxymatrine reverses epithelial-mesenchymal transition in breast cancer cells by depressing αⅤβ3 integrin/FAK/PI3K/Akt signaling activation | Q93185098 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | cell migration | Q189092 |
| | vulva squamous cell carcinoma | Q18554997 |
| P304 | page(s) | 2057-2067 | |
| P577 | publication date | 2020-03-19 | |
| P1433 | published in | Cancer Management and Research | Q5031417 |
| P1476 | title | Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway | |
| P478 | volume | 12 | |